Search Results 381-390 of 16961 for Linaclotide

  1. MC250412 Phase 2B Study To Determine Efficacy Of HRX215, A First Generation MKK4 Inhibitor Drug, In Improving Regeneration Of The Remnant Liver After Portal Vein Embolization (PVE) Of Colorectal Liver Metastasis (CRLM) - Mayo Clinic

    Colorectal cancer (CRC) is a malignant disease of the colon or rectum and represents the third most frequently diagnosed cancer in both men and women.

  2. Gastroenterology and Hepatology - Clinical trials

    One uncontrolled, unpublished study suggests that a footstool improved bowel symptoms in nearly 98% of 153 constipated participants. The purpose of this study ...

  3. Clinical trials - Oncology (Medical)

    Venetoclax is FDA approved for the treatment of CLL and SLL. The drug combination of acalabrutinib, durvalumab, and venetoclax is experimental and isn't ...

  4. Aminolevulinic acid (topical route) - Side effects & uses - Mayo Clinic

    Aminolevulinic acid gel is used in combination with photodynamic therapy (PDT) using BF-RhodoLED® or RhodoLED® XL lamps to treat mild to moderate actinic ...

  5. Gastroenterology and Hepatology - Clinical trials

    Rochester, Minn. The purpose of this study is to create a registry of obese patients who have been phenotyped to understand the heterogeneity of obesity. Celiac ...

  6. Clinical trials - Gastroenterology and Hepatology

    Mayo Clinic's Division of Gastroenterology and Hepatology offers treatment and specialty care for people with a wide range of rare and common digestive ...

  7. A Study To Evaluate Prevention Of Paclitaxel-Associated Neuropathy With Fingolimod - Mayo Clinic

    The purpose of this study is to determine if the use of Gilenya® can reduce neuropathy caused by paclitaxel. Participation eligibility. Participant eligibility ...

  8. Clinical trials - Oncology (Medical)

    Also, we will evaluate whether the peripheral blood immune cell function is different in B/AA prostate cancer patients with metastatic disease as compared with ...

  9. A Study To Learn About The Medicine Ponsegromab In Adults With Cancer Of The Pancreas Which Has Spread And Caused Significant Body Weight Loss And Fatigue - Mayo Clinic

    A Study To Learn About The Medicine Ponsegromab In Adults With Cancer Of The Pancreas Which Has Spread And Caused Significant Body Weight Loss And Fatigue.

  10. Clinical trials - Oncology (Medical)

    (Z)-endoxifen belongs to a group of drugs called selective estrogen receptor modulators or "SERM", which help block estrogen from attaching to cancer cells.